Angiex Featured in Labiotech’s Guide to Building a Biotech Company
Angiex was highlighted as one of only a handful of companies in Labiotech’s expert feature on building a successful biotech startup. In the article, Angiex’s CEO, Paul Jaminet, shared insights on how the supportive ecosystem in Cambridge has been essential to Angiex’s growth.
“For entrepreneurs, the advantage of having ready access to expertise, capital, and a company incubation ecosystem is hard to overstate,” Jaminet noted. He emphasized that the resources and community in Cambridge made it “immensely helpful” for Angiex to operate efficiently and advance its pioneering TM4SF1-directed therapies.
Labiotech’s recognition of Angiex highlights the company’s innovation in the biotech space and the importance of its location in fueling its progress toward next-generation cancer treatments. To see the entire story, read on.